| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/14/2009 | CN101342146A Preparation method of glimepiride tablet |
| 01/14/2009 | CN101342145A Medicinal fine pellet core and preparation method |
| 01/14/2009 | CN101342142A Temperature sensing in situ gel rubber formulations capable of being injected, preparation method and uses thereof |
| 01/14/2009 | CN101342141A Method for manufacturing organic metal anti-cancer medicine micro-nono-fibre having shell-core structure with coaxial cospinning technique |
| 01/14/2009 | CN100451646C Method for determining capsaicin flexible liposome encapsulation rate using dextran microgel column |
| 01/14/2009 | CN100450554C Medical adhesive composition, adhesive tape therefrom and endermic absorbed adhesive tape products |
| 01/14/2009 | CN100450550C Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 01/14/2009 | CN100450549C Solubilization carrier for drug, its preparation method and application |
| 01/14/2009 | CN100450548C Oral patches containing pdacrilin resin composition and its preparing method |
| 01/14/2009 | CN100450547C Medicinal compositions for improving oral absorption |
| 01/14/2009 | CN100450542C Formulation for a protein pharmaceutical without added human serum albumin (HSA) |
| 01/14/2009 | CN100450488C Soft steroid compositions for use in dry powder inhalers |
| 01/14/2009 | CN100450484C Imiquimod turbid liquor and gelling agent thereof |
| 01/14/2009 | CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers |
| 01/14/2009 | CN100450481C Compound medicine contg. famotidine cyclodextrin clathrate, and its prepn. method |
| 01/14/2009 | CN100450480C Aquogel type thiamazole plaster preparation |
| 01/14/2009 | CN100450476C Electrolyte complementary medical combination for injection |
| 01/14/2009 | CN100450475C Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 01/14/2009 | CN100450473C Aseptic medicinal composition |
| 01/14/2009 | CN100450471C Soft capsule of atovastatine salts and prepn. method therefor |
| 01/14/2009 | CN100450470C Rapid disintegrate tablet in oral and its preparation method |
| 01/14/2009 | CN100450469C Starch oral colon-target aqueous gel and its preparation method and use |
| 01/13/2009 | US7476725 two polymer molecules attached at a single site on a biomolecule; water soluble and have beneficial pharmacological properties, such as reduced immunogenicity and increased circulation time |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476694 Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles |
| 01/13/2009 | US7476693 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 01/13/2009 | US7476692 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476658 Conjugate for treating prokaryotic infections |
| 01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
| 01/13/2009 | US7476652 by addition of surfactants such as nonionic surfactants of the (poly)ethoxylated fatty acid type; storage stability to hydrophobic aggregation nuclei for several months under temperature stress |
| 01/13/2009 | US7476400 Liposomes containing an oil phase comprising topical anestheic, a C14-C20 alcohol, an alkyl ester of a fatty acid, propylene glycol, and a polyoxyalkylene stearate. |
| 01/13/2009 | US7476399 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products |
| 01/13/2009 | US7476396 Composition for removing abnormal keratinous material |
| 01/13/2009 | US7476380 Using vitamin A and/or the derivatives and/or the esters for therapy and prophylaxis, side effect reduction |
| 01/13/2009 | CA2400312C Nutritional intervention composition for enhancing and extending satiety |
| 01/13/2009 | CA2395333C Hydrogel-driven drug dosage form |
| 01/13/2009 | CA2374729C Novel organic anion transport proteins |
| 01/13/2009 | CA2340118C Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| 01/13/2009 | CA2315975C Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/13/2009 | CA2241322C Sustained-release preparation and its production |
| 01/13/2009 | CA2185653C Stabilization of peptides and proteins for radiopharmaceutical use |
| 01/08/2009 | WO2009006579A1 Peptide-polymer conjugates |
| 01/08/2009 | WO2009006097A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005839A2 Conjugates of compounds binding the steroid hormone receptor and their use as anticancer drugs |
| 01/08/2009 | WO2009005716A1 Utilization of artificial human lipids reconstituted as artificial tears for the stabilization application of ophthalmic therapeutics |
| 01/08/2009 | WO2009005353A1 High binding oligosaccharide compounds, compositions and uses thereof |
| 01/08/2009 | WO2009005152A1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel |
| 01/08/2009 | WO2009005000A1 Composition for mucosal administration containing agent for accelerating mucosal absorption of peptide drug and administration method thereof |
| 01/08/2009 | WO2009004999A1 Seamless capsule |
| 01/08/2009 | WO2009004873A1 Prostaglandin derivative-containing aqueous liquid agent |
| 01/08/2009 | WO2009004495A2 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 01/08/2009 | WO2009004440A2 Quick dissolve compositions of memantine hydrochloride |
| 01/08/2009 | WO2009004331A1 Body fluid expanders comprising n-substituted aminosulfonic acid buffers |
| 01/08/2009 | WO2009003965A1 Injectable veterinary composition with anti-prolactin activity |
| 01/08/2009 | WO2009003624A1 Hyaluronic acid derivatives containing groups able to release no |
| 01/08/2009 | WO2009003493A2 Mhc multimers, methods for their generation, labeling and use |
| 01/08/2009 | WO2009003492A1 Mhc multimers, methods for their generation, labeling and use |
| 01/08/2009 | WO2008143957A3 Hydrogel materials |
| 01/08/2009 | WO2008120098A3 Peptide prodrugs |
| 01/08/2009 | WO2008118133A3 Silk microspheres for encapsulation and controlled release |
| 01/08/2009 | WO2008109005A3 Use of anti-cd22 immunotoxins and protein-synthesis-inhibiting chemotherapeutic agents in treatment of b cell cancers |
| 01/08/2009 | WO2008107471A3 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 01/08/2009 | WO2008101175A3 Protein formulations containing sorbitol |
| 01/08/2009 | WO2007029198A3 Sanitary napkins with hydrophobic lotions |
| 01/08/2009 | US20090012241 Hydrolytically stable maleimide-terminated polymers |
| 01/08/2009 | US20090012184 Production of Dosage Forms Comprising a Solid Dispersion of a Microcrystalline Agent |
| 01/08/2009 | US20090012150 Stablized Pharmaceutical Composition Comprising an Amorphous Active Substance |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012028 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof |
| 01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/08/2009 | US20090011933 Materials having crosslinked polyrotaxane and process for producing the same |
| 01/08/2009 | US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 01/08/2009 | US20090011039 Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof |
| 01/08/2009 | US20090011037 Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof |
| 01/08/2009 | US20090011035 Personal care composition |
| 01/08/2009 | US20090011034 Sustained release micropellets and process for producing the same |
| 01/08/2009 | US20090011031 Delivery of oral drugs |
| 01/08/2009 | US20090011028 Self-precipitating pharmaceutical formulations for the moified release of an active principle |
| 01/08/2009 | US20090011024 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers |
| 01/08/2009 | US20090011014 Tablet Formulation for Sustained Drug-Release |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090011007 Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water |
| 01/08/2009 | US20090011004 Improved carriers for delivery of nucleic acid agents to cells and tissues |
| 01/08/2009 | US20090010999 Complex Particles and Coated Complex Particles |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010983 Alginate Coated, Polysaccharide Gel-Containing Foam Composite, Preparative Methods, and Uses Thereof |
| 01/08/2009 | US20090010968 Spot-on formulation useful for cosmetology and dermatology |
| 01/08/2009 | US20090010967 Clostridial toxin derivatives and methods for treating pain |
| 01/08/2009 | US20090010964 Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010882 Polymorphs of sodium 4-4[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 01/08/2009 | US20090010869 Compositions for Topical Enzymatic Debridement |
| 01/08/2009 | US20090010862 Foaming oil compositions |
| 01/08/2009 | US20090010861 Modified Plant Gums for Preparations of Active Ingredients |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | US20090008820 Injection Molded Water-Soluble Container |
| 01/08/2009 | DE102008006886A1 Composition, useful for raw material for pharmaceutical material, food, nutrient, hygiene and health products or cosmetic product, comprises tubular graphite carbon compound |
| 01/08/2009 | CA2692231A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |